Baby in hospital

Global Health Studies

Numerous studies around the globe are actively investigating the connection between Newborn Gut Deficiency and restoring our good bacteria, activated B. infantis EVC001, to the infant gut microbiome. From eczema to severe acute malnutrition to Type 1 diabetes, our research partners are engaged in potentially revolutionary studies investigating the starring role that activated B. infantis EVC001 may play in global health. 

Evivo B. infantis study on Malnutrition

Malnutrition Study

In partnership with Bill & Melinda Gates Foundation and icddr,b, this study seeks to evaluate the impact of activated B. infantis EVC001 on improved growth and anthropometric response in SAM babies and the subsequent impact on enteric inflammation.

LEARN MORE

Evivo B. infantis study on Type I Diabetes

Type 1 Diabetes Prevention Study

An international consortium is conducting a trial to investigate if daily feeding with activated B. infantis EVC001 during the first year of life can mitigate the development of Type I autoimmune diabetes.

LEARN MORE

Evivo B. infantis study on Dermatitis

Dermatitis Study

In partnership with Johnson & Johnson, and Janssen this study is assessing the effect of activated B. infantis EVC001 supplementation in breastfed infants on Atopic Dermatitis during the first year of life.
 

LEARN MORE

Evivo baby probiotic sachets

Evivo.
The first and only baby probiotic of its kind.

Evivo is clinically proven to restore a healthy gut in your baby. A daily infant probiotic powder, Evivo mixed with breast milk and fed to babies helps release nutrients in breast milk to create a protective environment in baby's gut. It also helps develop a baby's metabolism and immune system and builds the foundation for good health that lasts a lifetime. 

Learn more